417 related articles for article (PubMed ID: 31070941)
21. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and Management of Statin Intolerance.
Alonso R; Cuevas A; Cafferata A
J Atheroscler Thromb; 2019 Mar; 26(3):207-215. PubMed ID: 30662020
[TBL] [Abstract][Full Text] [Related]
23. Statin intolerance.
Laufs U; Scharnagl H; März W
Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
[TBL] [Abstract][Full Text] [Related]
24. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
[TBL] [Abstract][Full Text] [Related]
25. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK;
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575
[TBL] [Abstract][Full Text] [Related]
26. Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.
Cho L; Rocco M; Colquhoun D; Sullivan D; Rosenson RS; Dent R; Xue A; Scott R; Wasserman SM; Stroes E
Cardiovasc Drugs Ther; 2016 Jun; 30(3):297-304. PubMed ID: 26936841
[TBL] [Abstract][Full Text] [Related]
27. SAMSON and the Nocebo Effect: Management of Statin Intolerance.
Krishnamurthy A; Bradley C; Ascunce R; Kim SM
Curr Cardiol Rep; 2022 Sep; 24(9):1101-1108. PubMed ID: 35759168
[TBL] [Abstract][Full Text] [Related]
28. Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.
Taylor BA; Thompson PD
Curr Opin Lipidol; 2015 Jun; 26(3):221-7. PubMed ID: 25943841
[TBL] [Abstract][Full Text] [Related]
29. Clinical features related to statin-associated muscle symptoms.
Ochs-Balcom HM; Nguyen LM; Ma C; Isackson PJ; Luzum JA; Kitzmiller JP; Tarnopolsky M; Weisman M; Christopher-Stine L; Peltier W; Wortmann RL; Vladutiu GD
Muscle Nerve; 2019 May; 59(5):537-543. PubMed ID: 30549046
[TBL] [Abstract][Full Text] [Related]
30. [Statin-associated muscle symptoms].
Klose G
MMW Fortschr Med; 2018 Jan; 160(1):40-43. PubMed ID: 29335944
[No Abstract] [Full Text] [Related]
31. [Statin-associated muscle symptoms : Current management in 2018].
Kosinski C; Tran C; Kuntzer T; Rodondi N; Collet TH
Rev Med Suisse; 2018 Feb; 14(596):462-469. PubMed ID: 29489126
[TBL] [Abstract][Full Text] [Related]
32. Management of statin-intolerant patient.
Arca M; Pigna G; Favoccia C
Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
[TBL] [Abstract][Full Text] [Related]
33. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.
Sarzani R; Allevi M; Giulietti F; Sarnari S; Scorcella S; Di Agostini A; Turri P; Di Pentima C; Spannella F
Nutr Metab Cardiovasc Dis; 2024 Jan; 34(1):136-144. PubMed ID: 37798232
[TBL] [Abstract][Full Text] [Related]
34. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
[TBL] [Abstract][Full Text] [Related]
35. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
36. Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.
Herrett E; Williamson E; Beaumont D; Prowse D; Youssouf N; Brack K; Armitage J; Goldacre B; MacDonald T; Staa TV; Roberts I; Shakur-Still H; Smeeth L
BMJ Open; 2017 Dec; 7(12):e016604. PubMed ID: 29197834
[TBL] [Abstract][Full Text] [Related]
37. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis.
Irwin JC; Khalesi S; Fenning AS; Vella RK
Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224
[TBL] [Abstract][Full Text] [Related]
38. The Challenge: Finding the Most Appropriate Statin and Dose for Each Patient.
Lillo JL
J Fam Pract; 2021 Jul; 70(6S):S53-S58. PubMed ID: 34432625
[TBL] [Abstract][Full Text] [Related]
39. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
[TBL] [Abstract][Full Text] [Related]
40. Advances in the management of statin myopathy.
Gallo A; Perregaux J; Bruckert E
Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
